Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments.

4 , 5 Although physicians preferred CAR‐T administration, on average, they also preferred treatments with oral administration and monitoring every 6 weeks to intravenous administration (although this effect did not reach statistical significance, potentially due to lack of statistical power and variability among responses).

also in 111,027 other papers